Matthew Jarpe

7.1k citations

47 papers · 5.5k indexed · 2 hit papers · h-index 27

Impact in

Molecular Biology top 1%
- Histone Deacetylase Inhibitors Research
- Melanoma and MAPK Pathways
- Protein Kinase Regulation and GTPase Signaling
- Protein Degradation and Inhibitors
- Cell death mechanisms and regulation
Oncology top 2%
- Peptidase Inhibition and Analysis

Papers in

Hematology 8
- Multiple Myeloma Research and Treatments 5
Molecular Biology 41
- Histone Deacetylase Inhibitors Research 24
- Melanoma and MAPK Pathways 6
- Protein Degradation and Inhibitors 5
- Protein Kinase Regulation and GTPase Signaling 5

Co-authors: Gary L. Johnson Christian Widmann Spencer B. Gibson Pär Gerwins Gary R. Fanger John H. van Duzer Nancy L. Johnson Ralph Mazitschek
Journals: Blood (7 papers)Journal of Biological Chemistry (3 papers)Acta Neuropathologica Communications (2 papers)Journal of Clinical Investigation (2 papers)Brain Behavior and Immunity (2 papers)
Partner nations: United States Italy Belgium

In The Last Decade

Matthew Jarpe

47 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma 2012 · 488 citations

Peers

Countries citing papers authored by Matthew Jarpe

Since Specialization

Citations

This map shows the geographic impact of Matthew Jarpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Jarpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Jarpe more than expected).

Fields of papers citing papers by Matthew Jarpe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Jarpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Jarpe. The network helps show where Matthew Jarpe may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Jarpe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Jarpe Line = papers co-authored together Matthew Jarpe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice Psychopharmacology ·Farhana Sakloth, C. Hanifin, Kleopatra Avrampou, Vasiliki Mitsi, Randal A. Serafini, Kerri D. Pryce, Kgomotso Khunoane, Olivier Berton, Matthew Jarpe, Venetia Zachariou	2020	24
2	Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus Frontiers in Immunology ·Jingjing Ren, Michelle D. Catalina, Kristin Eden, Xiaofeng Liao, Kaitlin A. Read, Xin Luo, Ryan P. McMillan, Matthew W. Hulver, Matthew Jarpe, Prathyusha Bachali, Amrie C. Grammer, Peter E. Lipsky, Christopher M. Reilly	2019	32
3	Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment Acta Neuropathologica Communications ·Jiacheng Ma, XiaoJiao Huo, Matthew Jarpe, Annemieke Kavelaars, Cobi J. Heijnen	2018	54
4	HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy Pain ·Karen Krukowski, Jiacheng Ma, Olga Golonzhka, Geoffroy Laumet, Przemyslaw Szarejko, John H. van Duzer, Ralph Mazitschek, Matthew Jarpe, Cobi J. Heijnen, Annemieke Kavelaars	2017	145
5	HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia Leukemia ·Gcotgina Parry, Danielle P. Johnson, Samuel Bennett, Sepideh Faridi, M Urbaniak, Simon S. Jones, Jeffrey R. Shearstone, Steven N. Quayle, Chengyin Min, Matthew Jarpe, Tim Mosbruger, Anthony D. Pomicter, Rodney R. Miles, Wenyong Chen, Kapil N. Bhalla, Patrick A. Zweidler‐McKay, Dennis C. Shrieve, Michael W. Deininger, Mahesh B. Chandrasekharan, Srividya Bhaskara	2017	34
6	Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth Neurobiology of Disease ·Lawrence Van Helleputte, Ada Setelah, Dana P. Cook, I. Julien, Elisabeth Rossaert, Wanda Haeck, Tom Jaspers, Feng-Chih Chang, Pieter Vanden Berghe, Conny Gysemans, Chantal Mathieu, Wim Robberecht, Philip Van Damme, Guido Cavaletti, Matthew Jarpe, Ludo Van Den Bosch	2017	54
7	HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy Brain Behavior and Immunity ·Jiacheng Ma, Karen Krukowski, Olga Golonzhka, Geoffroy Laumet, Przemyslaw Szarejko, John H. van Duzer, Ralph Mazitschek, Matthew Jarpe, Cobi J. Heijnen, Annemieke Kavelaars	2017	1
8	Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia PLoS ONE ·Chengyin Min, Nathan W. Moore, Jeffrey R. Shearstone, Steven N. Quayle, Pengyu Huang, John H. van Duzer, Matthew Jarpe, Simon S. Jones, Min Yang	2017	19
9	Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease Neurotherapeutics ·Veronick Benoy, Pieter Vanden Berghe, Matthew Jarpe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch	2016	69
10	Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2 PLoS ONE ·Jeffrey R. Shearstone, Olga Golonzhka, Apurva Chonkar, David Tamang, John H. van Duzer, Simon S. Jones, Matthew Jarpe	2016	28
11	Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance Human Molecular Genetics ·Casey Cook, Yari Carlomagno, Tania F. Gendron, Judy H. Dunmore, M.D. Castro, Caroline Stetler, Mary Dabney Davis, Dennis W. Dickson, Matthew Jarpe, Michael DeTure, Leonard Petrucelli	2013	225
12	Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework Methods ·Бухалкин Данила Дмитриевич, Joseph W. Arndt, Ling Ling Chen, Matthew Jarpe, P. Ann Boriack‐Sjodin, You Li, Herman van Vlijmen, R. Blake Pepinsky, Kenneth J. Simon, Alexey A. Lugovskoy	2013	19
13	Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability Neuropsychopharmacology ·Jeanine Jochems, Janette Boulden, Ayse Erozan, Julie A. Blendy, Matthew Jarpe, Ralph Mazitschek, John H. van Duzer, Simon Jones, Olivier Berton	2013	135
14	Influence of canonical structure determining residues on antibody affinity and stability Journal of Structural Biology ·Louis A. Clark, Stephen J. Demarest, John Eldredge, Matthew Jarpe, You Li, С. М. Киселёв, Herman van Vlijmen	2013	2
15	Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody Protein Engineering Design and Selection ·Carl E. Reid, Mia Rushe, Matthew Jarpe, Herman van Vlijmen, Brian Dolinski, Qian Fang, Teresa G. Cachero, J J Roberts, kml dIp isMG, Razie Ghorbani, Xin Wang, P.P. Tereshkov, Ellen A. Garber, Véronique Bailly, Antonin de Fougerolles, P. Ann Boriack‐Sjodin	2006	29
16	Affinity enhancement of an in vivo matured therapeutic antibody using structure‐based computational design Protein Science ·Louis A. Clark, P. Ann Boriack‐Sjodin, John Eldredge, C. R. Laxmi, Bethany Friedman, Бухалкин Данила Дмитриевич, Matthew Jarpe, Stefano F. Liparoto, You Li, Alexey A. Lugovskoy, Stephan Miller, Mia Rushe, Woody Sherman, Kenneth J. Simon, Herman van Vlijmen	2006	136
17	Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines Circulation ·Esther Lutgens, Birgit Faber, D. C. Sands, Chris T. Evelo, Taro Takemoto, Sylvia Heeneman, Kitty B.J.M. Cleutjens, Ann Pascale Bijnens, Linda Beckers, J. Gordon Porter, Charles R. Mackay, Paul D. Rennert, Véronique Bailly, Matthew Jarpe, Brian Dolinski, Victor Koteliansky, C.T. Ituassu, Mat J.A.P. Daemen	2005	81
18	Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo Journal of Clinical Investigation ·Heather B. Adkins, Caterina Bianco, Susan G. Schiffer, Paul Rayhorn, Mohammad Zafari, Anne E. Cheung, Olivia Orozco, Dian L. Olson, Antonella De Luca, Ling Ling Chen, Konrad Miatkowski, Anne Argollo, Nicola Normanno, Kevin P. Williams, Matthew Jarpe, Doreen LePage, David S. Salomon, Michele Sanicola	2003	134
19	Apoptosis Stimulated by the 91-kDa Caspase Cleavage MEKK1 Fragment Requires Translocation to Soluble Cellular Compartments Journal of Biological Chemistry ·Thomas K. Schlesinger, А.А. Токанбаев, Matthew Jarpe, Gary R. Fanger, Jean‐René Cardinaux, Gary L. Johnson, Christian Widmann	2002	38
20	Signal Transduction Pathways Regulated by Mitogen-activated/Extracellular Response Kinase Kinase Kinase Induce Cell Death Journal of Biological Chemistry ·Nancy L. Johnson, Anne M. Gardner, Katrina Diener, Carol A. Lange, Rugaiyah Rugaiyah, Matthew Jarpe, Audrey Minden, Michael Karin, Leonard I. Zon, Gary L. Johnson	1996	315

About Matthew Jarpe

Matthew Jarpe is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Anesthesiology and Pain Medicine, having authored 47 papers that have together received 5.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (24 papers), Peptidase Inhibition and Analysis (7 papers), Melanoma and MAPK Pathways (6 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (5 papers), Protein Degradation and Inhibitors (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Molecular Biology (4.0k citations), Oncology (1.1k citations), Cell Biology (530 citations), Cancer Research (450 citations) and Immunology (598 citations). Matthew Jarpe has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Gary L. Johnson, Christian Widmann, Spencer B. Gibson, Pär Gerwins, Gary R. Fanger, John H. van Duzer, Nancy L. Johnson, Ralph Mazitschek, Simon S. Jones and Min Yang. Their work appears in journals such as Blood, Journal of Biological Chemistry, Acta Neuropathologica Communications, Journal of Clinical Investigation and Brain Behavior and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact